Skip to main content
Top
Published in: Archives of Virology 8/2014

01-08-2014 | Original Article

Genetic diversity of hepatitis C virus quasispecies in chronic renal failure patients in Midwest Brazil

Authors: Regina Maria Santos de Amorim, Alexandre Coelho, Elisabeth Lampe, Tainá Raiol, Regina Maria Bringel Martins

Published in: Archives of Virology | Issue 8/2014

Login to get access

Abstract

Hepatitis C virus (HCV) quasispecies constitute a dynamic population in a continuous process of variation and selection. To investigate effect of the immune system on the genetic variability of HCV, we compared the hypervariable region 1 (HVR1) of immunosuppressed patients with chronic renal failure (CRF group) to immunocompetent patients with HCV chronic infection (control group). The HVR1 from ten samples of each group was amplified, cloned and sequenced. The HCV quasispecies from the control group had a higher frequency of variable sites in HVR1 (83.9 % vs 59.3 %, p < 0.05), as well as a greater diversity within (intra-patient) and between samples, compared to the CRF group. The clustering of the majority of the quasispecies of the CRF group in the phylogenetic tree also showed the limited diversity of the quasispecies in immunosuppressed patients. Moreover, a higher variability of amino acids at positions 384, 386, 391, 394, 397, 398, 400, 405 and 410 was observed in the control group than in the CRF group, which showed a greater variability only at position 388 (p < 0.05). These data corroborates the hypothesis that the major selective pressure factor is the immune system, which promotes a high degree of diversity in the viral progeny and contributes to a constant evolution of HCV.
Literature
2.
go back to reference Ghany MG, Strader DB, Thomas DL, Seeff LB (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49(4):1335PubMedCrossRef Ghany MG, Strader DB, Thomas DL, Seeff LB (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49(4):1335PubMedCrossRef
3.
go back to reference Su Y, Norris JL, Zang C, Peng Z, Wang N (2013) Incidence of hepatitis C virus infection in patients on hemodialysis: A systematic review and meta-analysis. Hemodial Intern 17(4):532 Su Y, Norris JL, Zang C, Peng Z, Wang N (2013) Incidence of hepatitis C virus infection in patients on hemodialysis: A systematic review and meta-analysis. Hemodial Intern 17(4):532
4.
go back to reference Fabrizi F, Dixit V, Messa P (2012) Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality? J Viral Hepat 19(9):601PubMedCrossRef Fabrizi F, Dixit V, Messa P (2012) Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality? J Viral Hepat 19(9):601PubMedCrossRef
5.
go back to reference Chevaliez S, Pawlotsky JM (2007) Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13(17):2461PubMed Chevaliez S, Pawlotsky JM (2007) Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13(17):2461PubMed
6.
go back to reference Pawlotsky JM (2006) Quasispecies: concept and implications for virology. Curr Top Microbiol Immunol 299:261PubMed Pawlotsky JM (2006) Quasispecies: concept and implications for virology. Curr Top Microbiol Immunol 299:261PubMed
7.
go back to reference Farci P, Purcell RH, et al (2000) Clinical significance of hepatitis C virus genotypes and quasispecies. In: Seminars in liver diseases, vol 20, no. 1, GEORG THIEME VERLAG, Leipzi, pp 103–126 Farci P, Purcell RH, et al (2000) Clinical significance of hepatitis C virus genotypes and quasispecies. In: Seminars in liver diseases, vol 20, no. 1, GEORG THIEME VERLAG, Leipzi, pp 103–126
8.
go back to reference Penin F, Combet C, Germanidis G, Frainais PO, Deléeage G, Pawlotsky JM (2001) Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 75(12):5703PubMedCentralPubMedCrossRef Penin F, Combet C, Germanidis G, Frainais PO, Deléeage G, Pawlotsky JM (2001) Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 75(12):5703PubMedCentralPubMedCrossRef
9.
go back to reference Simmonds P, Bukh J, Combet C, Deléeage G, Enomoto N, Feinstone S, Halfon P, Inchauspé G, Kuiken C, Maertens G et al (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962PubMedCrossRef Simmonds P, Bukh J, Combet C, Deléeage G, Enomoto N, Feinstone S, Halfon P, Inchauspé G, Kuiken C, Maertens G et al (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42(4):962PubMedCrossRef
10.
go back to reference Martell M, Esteban J, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J (1992) Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 66(5):3225PubMedCentralPubMed Martell M, Esteban J, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J (1992) Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 66(5):3225PubMedCentralPubMed
11.
go back to reference Dubuisson J (2007) Hepatitis C virus proteins. World J Gastroenterol 13(17):2406PubMed Dubuisson J (2007) Hepatitis C virus proteins. World J Gastroenterol 13(17):2406PubMed
12.
go back to reference Li H, McMahon BJ, McArdle S, Bruden D, Sullivan DG, Shelton D, Deubner H, Gretch DR (2008) Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C. Virology 375(2):580PubMedCentralPubMedCrossRef Li H, McMahon BJ, McArdle S, Bruden D, Sullivan DG, Shelton D, Deubner H, Gretch DR (2008) Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C. Virology 375(2):580PubMedCentralPubMedCrossRef
13.
go back to reference Booth JC, Kumar U, Webster D, Monjardino J, Thomas HC (1998) Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 27(1):223PubMedCrossRef Booth JC, Kumar U, Webster D, Monjardino J, Thomas HC (1998) Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 27(1):223PubMedCrossRef
14.
go back to reference Fabrizi F, Lunghi G, Poordad F, Martin P (2002) Genetic variability of hepatitis C virus in dialysis: the implications. Intern J Artif Organs 25(11):1034 Fabrizi F, Lunghi G, Poordad F, Martin P (2002) Genetic variability of hepatitis C virus in dialysis: the implications. Intern J Artif Organs 25(11):1034
15.
go back to reference Sheridan I, Pybus OG, Holmes EC, Klenerman P (2004) High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression. J Virol 78(7):3447PubMedCentralPubMedCrossRef Sheridan I, Pybus OG, Holmes EC, Klenerman P (2004) High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression. J Virol 78(7):3447PubMedCentralPubMedCrossRef
16.
go back to reference Qin H, Shire NJ, Keenan ED, Rouster SD, Eyster ME, Goedert JJ, Koziel MJ, Sherman KE et al (2005) HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood 105(2):533PubMedCrossRef Qin H, Shire NJ, Keenan ED, Rouster SD, Eyster ME, Goedert JJ, Koziel MJ, Sherman KE et al (2005) HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood 105(2):533PubMedCrossRef
17.
go back to reference Chen S, Wang YM (2007) Evolutionary study of hepatitis C virus envelope genes during primary infection. Chin Med J 120(24):2174PubMed Chen S, Wang YM (2007) Evolutionary study of hepatitis C virus envelope genes during primary infection. Chin Med J 120(24):2174PubMed
18.
go back to reference Hauser AB, Stinghen AE, Kato S, Bucharles S, Aita C, Yuzawa Y, Pecoits-Filho R (2008) Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Intern 28(Supplement 3):S183 Hauser AB, Stinghen AE, Kato S, Bucharles S, Aita C, Yuzawa Y, Pecoits-Filho R (2008) Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Intern 28(Supplement 3):S183
19.
go back to reference Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I (2007) Basic science and dialysis: disturbances of acquired immunity in hemodialysis patients. Semin Dial 20(5):440PubMedCrossRef Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I (2007) Basic science and dialysis: disturbances of acquired immunity in hemodialysis patients. Semin Dial 20(5):440PubMedCrossRef
20.
go back to reference Carneiro MA, Teles SA, Dias MA, Ferreira RC, Naghettine AV, Silva SA, Lampe E, Yoshida CF, Martins R (2005) Decline of hepatitis C infection in hemodialysis patients in Central Brazil: a ten years of surveillance. Memórias do Instituto Oswaldo Cruz 100(4):345PubMedCrossRef Carneiro MA, Teles SA, Dias MA, Ferreira RC, Naghettine AV, Silva SA, Lampe E, Yoshida CF, Martins R (2005) Decline of hepatitis C infection in hemodialysis patients in Central Brazil: a ten years of surveillance. Memórias do Instituto Oswaldo Cruz 100(4):345PubMedCrossRef
21.
go back to reference Togawa RC, Brígido MM (2003) Web based tool for simple electropherogram quality analysis. In: 1st International Conference on Bioinformatics and Computational Biology-IcoBiCoBi. Ribeirão Preto Togawa RC, Brígido MM (2003) Web based tool for simple electropherogram quality analysis. In: 1st International Conference on Bioinformatics and Computational Biology-IcoBiCoBi. Ribeirão Preto
22.
go back to reference Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22(22):4673PubMedCentralPubMedCrossRef Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22(22):4673PubMedCentralPubMedCrossRef
23.
go back to reference Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. In: Nucleic acids symposium series, vol. 41, pp 95–98 Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. In: Nucleic acids symposium series, vol. 41, pp 95–98
24.
go back to reference Kumar S, Nei M, Dudley J, Tamura K (2008) MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform 9(4):299PubMedCentralPubMedCrossRef Kumar S, Nei M, Dudley J, Tamura K (2008) MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform 9(4):299PubMedCentralPubMedCrossRef
26.
go back to reference Black SD, Mould DR (1991) Development of hydrophobicity parameters to analyze proteins which bear post-or cotranslational modifications. Anal Biochem 193(1):72PubMedCrossRef Black SD, Mould DR (1991) Development of hydrophobicity parameters to analyze proteins which bear post-or cotranslational modifications. Anal Biochem 193(1):72PubMedCrossRef
27.
go back to reference Odeberg J, Yun Z, Sönnerborg A, Bjøro K, Uhlén M, Lundeberg J (1997) Variation of hepatitis C virus hypervariable region 1 in immunocompromised patients. J Infect Dis 175(4):938PubMedCrossRef Odeberg J, Yun Z, Sönnerborg A, Bjøro K, Uhlén M, Lundeberg J (1997) Variation of hepatitis C virus hypervariable region 1 in immunocompromised patients. J Infect Dis 175(4):938PubMedCrossRef
28.
go back to reference Lawal Z, Petrik J, Wong VS, Alexander GJ, Allain JP (1997) Hepatitis C virus genomic variability in untreated and immunosuppressed patients. Virology 228(1):107PubMedCrossRef Lawal Z, Petrik J, Wong VS, Alexander GJ, Allain JP (1997) Hepatitis C virus genomic variability in untreated and immunosuppressed patients. Virology 228(1):107PubMedCrossRef
29.
go back to reference Toyoda H, Fukuda H, Koyama Y, Takamatsu J, Saito H, Hayakawa T (1997) Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol 26(5):975PubMedCrossRef Toyoda H, Fukuda H, Koyama Y, Takamatsu J, Saito H, Hayakawa T (1997) Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol 26(5):975PubMedCrossRef
30.
go back to reference López-Labrador FX, Dove L, Hui CK, Phung Y, Kim M, Berenguer M, Wright TL (2007) Trends for genetic variation of hepatitis C virus quasispecies in human immunodeficiency virus-1 coinfected patients. Virus Res 130(1):285PubMedCentralPubMedCrossRef López-Labrador FX, Dove L, Hui CK, Phung Y, Kim M, Berenguer M, Wright TL (2007) Trends for genetic variation of hepatitis C virus quasispecies in human immunodeficiency virus-1 coinfected patients. Virus Res 130(1):285PubMedCentralPubMedCrossRef
31.
go back to reference Sobolev B, Poroikov V, Olenina L, Kolesanova E, Archakov A et al (2000) Comparative analysis of amino acid sequences from envelope proteins isolated from different hepatitis C virus variants: possible role of conservative and variable regions. J Viral Hepat 7(5):368PubMedCrossRef Sobolev B, Poroikov V, Olenina L, Kolesanova E, Archakov A et al (2000) Comparative analysis of amino acid sequences from envelope proteins isolated from different hepatitis C virus variants: possible role of conservative and variable regions. J Viral Hepat 7(5):368PubMedCrossRef
32.
go back to reference Gaudy C, Moreau A, Veillon P, Temoin S, Lunel F, Goudeau A (2003) Significance of pretreatment analysis of hepatitis C virus genotype 1b hypervariable region 1 sequences to predict antiviral outcome. J Clin Microbiol 41(8):3615PubMedCentralPubMedCrossRef Gaudy C, Moreau A, Veillon P, Temoin S, Lunel F, Goudeau A (2003) Significance of pretreatment analysis of hepatitis C virus genotype 1b hypervariable region 1 sequences to predict antiviral outcome. J Clin Microbiol 41(8):3615PubMedCentralPubMedCrossRef
33.
go back to reference Sherman KE, Andreatta C, O’Brien J, Gutierrez A, Harris R (1996) Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology 23(4):688PubMedCrossRef Sherman KE, Andreatta C, O’Brien J, Gutierrez A, Harris R (1996) Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology 23(4):688PubMedCrossRef
Metadata
Title
Genetic diversity of hepatitis C virus quasispecies in chronic renal failure patients in Midwest Brazil
Authors
Regina Maria Santos de Amorim
Alexandre Coelho
Elisabeth Lampe
Tainá Raiol
Regina Maria Bringel Martins
Publication date
01-08-2014
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 8/2014
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-014-1994-6

Other articles of this Issue 8/2014

Archives of Virology 8/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.